Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
February 15, 2022 4:58 PM 2 min read

Sarah Palin Loses Her Libel Lawsuit Against The New York Times: What You Need To Know

by Dustin Blitchok Benzinga Editor
Follow
NYT Logo
NYTNew York Times Co
$72.94-%
Overview

A federal jury said Tuesday that former GOP vice presidential candidate and Alaska Gov. Sarah Palin’s libel lawsuit against the New York Times Co (NYSE:NYT) fell short.

The verdict comes one day after Jed S. Rakoff, the judge presiding in the case, said he would dismiss the case if the jury found in Palin’s favor.

An appeal is expected, the Times reported.

Palin V. The New York Times: The basis of the lawsuit is a 2017 Times editorial that “incorrectly linked Palin’s political rhetoric to a mass shooting,” according to the newspaper.

The editorial, which the Times corrected after it was published, linked Palin’s politics with a 2011 Tucson, Arizona mass shooting in which six people were killed and 14 were wounded, including then-Rep. Gabrielle Giffords, an Arizona Democrat.

Giffords’ district was one of 20 pictured on a map underneath digital crosshairs in a document circulated by Palin’s political action committee, the Times said; there was no evidence the mass shooter saw the map.

See Also: Bernie Sanders Lashes Out At Chipotle

Why It's Important: The lawsuit represents a test of the nation’s libel laws in the form of the freedom of the press granted by the First Amendment and the precedent set by the Supreme Court for claims of defamation by the media.

A prior ruling involving the same newspaper, 1964’s New York Times Co. v. Sullivan, held that litigants who are public figures must prove more than just a false statement by a journalist: they must prove a journalist showed actual malice in the publication of false information in order for the news organization to be held liable.

The High Court defined “actual malice” surrounding a falsehood as “knowledge that it was false or with reckless disregard of whether it was false or not.”

In delivering a verdict against Palin, the jury decided she didn't meet that test.

The case has taken several notable turns. Rakoff’s statement that he would throw out the case came while the jury was still deliberating.

The trial was delayed after Palin, 58, tested positive for the coronavirus. She was later spotted dining in a Manhattan restaurant despite the test result and being unvaccinated; New York City requires proof of vaccination for indoor dining.

What’s Next: Palin is expected to appeal to the 2nd Circuit Court of Appeals, Axios reported, adding that her desire to challenge the actual malice standard for libel would have to go to the Supreme Court.

“I think a lot of media companies and lawyers representing media companies are probably breathing a big sigh of relief right now,” Christy Hull Eikhoff, a media and defamation lawyer at Alston & Bird, told Axios.

Photo: Gage Skidmore, Flickr

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsPoliticsLegalTop StoriesMediaGeneralThe New York Times
NYT Logo
NYTNew York Times Co
$72.94-%
Overview
Comments
Loading...